News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
China Resources Pharmaceutical (03320.HK) Subsidiary's 1,4-Butanediamine Introduced into Downstream Client's New Product System
China Resources Pharmaceutical (03320.HK) announced that Shenzhou Bio, a business unit under China Resources Double-Crane, achieved a significant breakthrough in the industrial app...
Reset
Send
The window will close in 5 seconds
China Resources Pharmaceutical (03320.HK) Subsidiary's 1,4-Butanediamine Introduced into Downstream Client's New Product System
Close
Recommend
2
Positive
0
Negative
3
 
 

China Resources Pharmaceutical (03320.HK)  -0.110 (-1.792%)    Short selling $65.09M; Ratio 42.540%   announced that Shenzhou Bio, a business unit under China Resources Double-Crane, achieved a significant breakthrough in the industrial application of synthetic biology. Its core bio-based product, 1,4-butanediamine, has been successfully incorporated into the newly launched Wouper PA46 bio-based high-performance polyamide material system of downstream partner Wote Co., Ltd., marking the Group's official entry into the terminal application field of high-performance materials.

The Wouper PA46 launched by Wote Co., Ltd. is positioned as a benchmark bio-based high-performance polyamide product. The material integrates the green attributes of bio-based raw materials with the stringent operating requirements of high-performance engineering plastics. It features multiple outstanding properties, including high strength, low creep, fatigue resistance, wide-temperature wear resistance, self-lubrication, high fluidity, weld resistance, oil resistance and hydrolysis resistance. It can be widely applied in high-end manufacturing sectors such as automotive transmission systems, precision electronics and the electrical industry, demonstrating strong downstream application potential. (ha/u)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-22 16:25.)



This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Auto-translated by AI

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.